Abrdn Healthcare Opportunities Fund logo

Abrdn Healthcare Opportunities Fund (THQ)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
17. 75
-0.03
-0.17%
$
771.15M Market Cap
- Div Yield
117,977 Volume
$ 17.78
Previous Close
Add Transaction
Day Range
17.7 17.94
Year Range
15.14 20.39
Want to track THQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

THQ closed today lower at $17.75, a decrease of -0.17% from yesterday's close, completing a monthly decrease of -5.48% or -$1.03. Over the past 12 months, THQ stock lost -8.22%.
THQ pays dividends to its shareholders, with the most recent payment made on May 29, 2026. The next estimated payment will be in In 3 weeks on Jun 29, 2026 for a total of $0.18.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NYSE (USD).

THQ Chart

Thank You, Seniors. Healthcare Spending Is Fueling Economic And Job Growth - THQ

Thank You, Seniors. Healthcare Spending Is Fueling Economic And Job Growth - THQ

Healthcare is the largest contributor to consumer spending and job growth. Healthcare's demographic tailwinds and essential nature underpin persistent demand. We discuss abrdn Healthcare Opportunities Fund, a high-quality fund to collect 12% yields from this critical sector.

Seekingalpha | 1 month ago
THQ: 13% Yield That Captures The Growth Of The Weight Loss Market (Rating Upgrade)

THQ: 13% Yield That Captures The Growth Of The Weight Loss Market (Rating Upgrade)

I am upgrading abrdn Healthcare Opportunities Fund to a 'Buy', citing positive catalysts and an attractive yield. THQ offers a 13% yield, broad healthcare exposure, and benefits from GLP-1 market expansion, but payout sustainability is a risk. Recent NAV declines and reliance on realized gains highlight the potential for a distribution cut if earnings don't improve.

Seekingalpha | 2 months ago
Switching From THQ To BME Despite The Yield

Switching From THQ To BME Despite The Yield

The abrdn Healthcare Opportunities Fund has delivered strong historical returns but now faces sustainability concerns due to leverage, premium to NAV, and likely fee waiver expiration. THQ's 11% yield is increasingly funded by return of capital, with NAV erosion and potential distribution cuts on the horizon. BlackRock Health Sciences Trust offers a safer alternative: a 7.5% yield, a conservative distribution policy, no leverage, a lower expense ratio, and currently trades at a 5.6% discount to NAV.

Seekingalpha | 4 months ago

Abrdn Healthcare Opportunities Fund Investors

Name Quantity Cost Value Profit ($) Gain (%)
CCP
Christopher C. Powers Farther Finance Advisors, LLC
114 $2,323 $2,021.22 -$301.78 -12.99%
AJB
ANDREW J. BARFOOT Madison Park Capital Advisors, LLC
14,000 $254,183 $248,220 -$5,963 -2.35%
JS
Joshua Stipcich Tidemark, LLC
320 $5,533 $5,673.6 $140.6 2.54%
SC
Stacy Creekmur Creekmur Asset Management LLC
722 $13,122.65 $12,801.06 -$321.59 -2.45%
HWP
Highline Wealth Partners LLC Highline Wealth Partners LLC
195 $3,372 $3,457.35 $85.35 2.53%

Abrdn Healthcare Opportunities Fund (THQ) FAQ

What is the stock price today?

The current price is $17.75.

On which exchange is it traded?

Abrdn Healthcare Opportunities Fund is listed on NYSE.

What is its stock symbol?

The ticker symbol is THQ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 771.15M.

Has Abrdn Healthcare Opportunities Fund ever had a stock split?

No, there has never been a stock split.

Abrdn Healthcare Opportunities Fund Profile

NYSE Exchange
US Country

Overview

The Abrdn Healthcare Opportunities Fund is a dedicated investment fund focusing on the healthcare industry, aiming to generate both income and capital growth for its investors. By targeting companies across various health-related sectors such as pharmaceuticals, biotechnology, medical devices, and healthcare services, the fund leverages demographic trends and technological advancements that are transforming the healthcare landscape worldwide. As a sector of continuous demand, healthcare represents a vital area for investment, offering exposure to critical services and innovations. The fund employs an active management strategy to identify companies with high growth potential and strong financial health, facilitating investment in both established and emerging entities within the healthcare sector. This strategic approach highlights the fund's role in providing investor access to a sector with substantial impacts on global economies and societal health.

Products and Services

The Abrdn Healthcare Opportunities Fund offers specialized investment opportunities through a diversified portfolio, focusing on:

  • Pharmaceuticals: Investments in companies developing and marketing drugs and treatments, benefiting from ongoing innovation and regulatory advancements that drive the sector.
  • Biotechnology: Targeting firms at the forefront of biological and genetic research, the fund taps into cutting-edge discoveries and therapies with the potential to redefine healthcare outcomes.
  • Medical Devices: The fund invests in producers of medical equipment and devices, focusing on innovations that improve patient care, diagnostic capabilities, and treatment outcomes.
  • Healthcare Services: Recognizing the importance of services ranging from hospital care to telehealth, the fund seeks to support companies that are enhancing access to and the efficiency of healthcare delivery.

Through its active management strategy, the Abrdn Healthcare Opportunities Fund aims to capitalize on established leaders and emerging innovators, driving growth and offering investor access to a critical and dynamic sector.

Contact Information

Address: 100 Federal Street
Phone: 215 405 5700